# | Title | Journal | Year | Citations |
---|
1 | Pulmonary aspergillosis: a clinical review | European Respiratory Review | 2011 | 533 |
2 | Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature | European Respiratory Review | 2012 | 421 |
3 | Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases | European Respiratory Review | 2018 | 370 |
4 | Epidemiology of COPD | European Respiratory Review | 2009 | 362 |
5 | Comorbidities of COPD | European Respiratory Review | 2013 | 353 |
6 | Antifibrotic activities of pirfenidone in animal models | European Respiratory Review | 2011 | 350 |
7 | Protecting healthcare workers from SARS-CoV-2 infection: practical indications | European Respiratory Review | 2020 | 313 |
8 | The pathophysiology of chronic thromboembolic pulmonary hypertension | European Respiratory Review | 2017 | 307 |
9 | Depression and anxiety in patients with COPD | European Respiratory Review | 2014 | 286 |
10 | Tuberculosis and lung damage: from epidemiology to pathophysiology | European Respiratory Review | 2018 | 279 |
11 | Acute high-altitude sickness | European Respiratory Review | 2017 | 273 |
12 | Impact of exacerbations on COPD | European Respiratory Review | 2010 | 244 |
13 | Cellular interactions in the pathogenesis of interstitial lung diseases | European Respiratory Review | 2015 | 231 |
14 | Scleroderma lung disease | European Respiratory Review | 2013 | 230 |
15 | Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension | European Respiratory Review | 2017 | 229 |
16 | Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma | European Respiratory Review | 2010 | 225 |
17 | Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment | European Respiratory Review | 2016 | 225 |
18 | Adult-onset asthma: is it really different? | European Respiratory Review | 2013 | 221 |
19 | Rheumatoid arthritis-associated lung disease | European Respiratory Review | 2015 | 220 |
20 | Dysfunctional breathing: a review of the literature and proposal for classification | European Respiratory Review | 2016 | 217 |
21 | Pulmonary alveolar proteinosis | European Respiratory Review | 2011 | 212 |
22 | Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years | European Respiratory Review | 2012 | 211 |
23 | The role of the right ventricle in pulmonary arterial hypertension | European Respiratory Review | 2011 | 210 |
24 | Pulmonary manifestations of Sjögren's syndrome | European Respiratory Review | 2016 | 206 |
25 | Practical recommendations for exercise training in patients with COPD | European Respiratory Review | 2013 | 200 |
26 | Spontaneous pneumothorax: epidemiology, pathophysiology and cause | European Respiratory Review | 2010 | 193 |
27 | Fibrosing interstitial lung diseases: knowns and unknowns | European Respiratory Review | 2019 | 191 |
28 | REVEAL: a contemporary US pulmonary arterial hypertension registry | European Respiratory Review | 2012 | 190 |
29 | Exacerbations of COPD | European Respiratory Review | 2018 | 189 |
30 | Cardiovascular disease and COPD: dangerous liaisons? | European Respiratory Review | 2018 | 187 |
31 | The right ventricle in pulmonary arterial hypertension | European Respiratory Review | 2014 | 185 |
32 | Climate change and respiratory diseases | European Respiratory Review | 2014 | 183 |
33 | Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension | European Respiratory Review | 2017 | 183 |
34 | Night-time symptoms: a forgotten dimension of COPD | European Respiratory Review | 2011 | 182 |
35 | Interstitial lung disease | European Respiratory Review | 2014 | 182 |
36 | Malignant pleural effusion: from bench to bedside | European Respiratory Review | 2016 | 179 |
37 | Obesity hypoventilation syndrome | European Respiratory Review | 2019 | 176 |
38 | The arterial load in pulmonary hypertension | European Respiratory Review | 2010 | 173 |
39 | Pathogenesis of pulmonary arterial hypertension: lessons from cancer | European Respiratory Review | 2013 | 172 |
40 | The role of small airways in obstructive airway diseases | European Respiratory Review | 2011 | 170 |
41 | ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases | European Respiratory Review | 2019 | 167 |
42 | Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype | European Respiratory Review | 2014 | 166 |
43 | Matrix abnormalities in pulmonary fibrosis | European Respiratory Review | 2018 | 165 |
44 | Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis | European Respiratory Review | 2017 | 162 |
45 | Cancer-associated thrombosis: the when, how and why | European Respiratory Review | 2019 | 160 |
46 | Physiology of the lung in idiopathic pulmonary fibrosis | European Respiratory Review | 2018 | 159 |
47 | Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK | European Respiratory Review | 2009 | 157 |
48 | The therapy of idiopathic pulmonary fibrosis: what is next? | European Respiratory Review | 2019 | 157 |
49 | An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan | European Respiratory Review | 2017 | 156 |
50 | The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies | European Respiratory Review | 2021 | 150 |